Mandate

Vinge advises Nordea and UBS in relation to Sanitec’s listing on NASDAQ OMX Stockholm

November 29, 2013

Vinge advises Nordea Bank AB (publ) and UBS Limited – joint global coordinators and bookrunners – in relation to Sanitec Oyj:s application for listing on NASDAQ OMX Stockholm. Sanitec’s principal shareholder is EQT. A prospectus was published on 27 November and the first day of trading on NASDAQ OMX Stockholm is expected to be 10 December.  

EQT may increase the offer and have also granted, among others, Nordea and UBS a customary over-allotment option. The total value of the offering amounts to approximately SEK 2.4 billion. Assuming the offering is increased in full, the total value of the offering amounts to approximately SEK 3.1 billion (and approximately SEK 3.6 billion assuming the over-allotment option is also exercised in full).  

Sanitec is the market leader in bathroom ceramics and a leading supplier of bathroom fixtures in its core markets (Belgium, Denmark, Finland, France, Germany, Italy, the Netherlands, Norway, Poland, Russia, Sweden, Ukraine, and the United Kingdom). Sanitec has leading positions (number one or two based on volume) in bathroom ceramics in 12 of its 13 core markets and command a strong position in growth markets, including Russia. Sanitec’s unique brand portfolio includes many of the longest-established and most well-known brands on the European bathroom fixtures market, including its ‘‘national jewels’’: Ifö® (Sweden and Denmark), Ido® (Finland and Sweden), Keramag® (Germany), Sphinx® (the Netherlands), Twyford® (United Kingdom), Allia® (France), Pozzi-Ginori® (Italy), Kolo® (Poland) and Colombo® (Ukraine). In 2012, Sanitec’s net sales amounted to EUR 752.8 million and the number of employees amounted to approximately 6,500.  

Vinge’s team consisted mainly of Peter Bäärnhielm and David Andersson.

Related

Vinge has advised Vitamin Well and its majority shareholders Cinven, Bridgepoint and the founders on Vitamin Well's combination with EMPWR

Vinge has advised Vitamin Well and its majority shareholders Cinven, the founders of Vitamin Well and Bridgepoint on Vitamin Well's acquisition of EMPWR Nutrition Group from majority seller Waterland Private Equity Investments.
July 03, 2026

Vinge has advised Morrow Bank in connection with its issuances of primary capital instruments (AT1) and tier 2 capital bonds (T2)

The issuances comprised perpetual AT1 bonds of NOK 300 million with a floating coupon of 3-month NIBOR + 425 basis points and a first call date in 2031, as well as subordinated Tier 2 bonds of SEK 200 million with a floating coupon of 3-month STIBOR + 325 basis points and a first call date in 2031. The bonds are intended to be admitted to trading on Nasdaq Stockholm.
July 03, 2026

Vinge advises Wihlborgs Fastigheter in connection with the financing of property acquisition valued at SEK 13.3 billion

Vinge advises Wihlborgs Fastigheter AB (publ) in connection with the financing of the acquisition of all of Castellum’s property holdings in Malmö, Lund and Helsingborg. The financing has been secured through Danske Bank, SEB and Swedbank.
June 29, 2026